[1] |
Zhang Baihong, Yue Hongyun.
Advances in anti-tumor drugs with new mechanisms of action
[J]. Journal of International Oncology, 2024, 51(6): 354-358.
|
[2] |
Wang Liwei, Liang Hongsheng, Du Songlin, Chen Zhihao, Wang Qing, Gao Aili.
Research progress of avermectins in anti-tumor
[J]. Journal of International Oncology, 2022, 49(6): 353-356.
|
[3] |
Li Liting, Gao Xiaoling.
TREM-2 and tumors
[J]. Journal of International Oncology, 2021, 48(2): 101-104.
|
[4] |
Hou Lina, Dina Suolitiken, Guo Zhi, Chen Xiao, Ren Hua.
Comparison of efficacy and safety of PD-1 inhibitor monotherapy and combined with chemotherapy/targeted therapy in advanced malignant tumors
[J]. Journal of International Oncology, 2020, 47(4): 193-198.
|
[5] |
Hou Yuanmei, Li Junpeng.
Recent advances in immunotherapy for relapsed or refractory multiple myeloma
[J]. Journal of International Oncology, 2020, 47(12): 765-768.
|
[6] |
Wang Shuang, Tang Yunyun, Yue Qi.
New progress in antitumor research of non-psychoactive cannabidiol
[J]. Journal of International Oncology, 2020, 47(10): 619-623.
|
[7] |
Jiang Jinquan, Liu Teli, Xia Lei, Zhu Hua, Yang Zhi.
PET probes of small molecule polypeptide immunosuppressive agents guiding tumor immunotherapy
[J]. Journal of International Oncology, 2019, 46(8): 449-452.
|
[8] |
Yi Lin, Qiu Shi.
Anti-tumor effect and mechanisms of shikonin on gliomas
[J]. Journal of International Oncology, 2019, 46(8): 489-491.
|
[9] |
Liang Jing1,3, Han Sha2, Yao Jing3, Kong Qingsheng2.
Effect of histone deacetylase and its inhibitor on tumor
[J]. Journal of International Oncology, 2019, 46(4): 235-238.
|
[10] |
Xiong Bobo, Zhang Jinsong, Li Ning, Wang Haifeng, Zuo Yigang, Wang Jiansong.
Molecular targeted therapy for advanced kidney cancer
[J]. Journal of International Oncology, 2019, 46(12): 705-710.
|
[11] |
Wang Gang, Wang Huangzhen, Xue Ting.
Effect of oxaliplatin induced autophagy on drug resistance of SGC7901 gastric cancer cells
[J]. Journal of International Oncology, 2018, 45(8): 513-518.
|
[12] |
Ling Xiaofei, Xu Ke, Shao Hua, Wang Cuijuan.
Anticancer mechanism and application of curcumin analog EF24
[J]. Journal of International Oncology, 2018, 45(3): 172-175.
|
[13] |
Liu Jingjing, Jin Caibao, Xu Xiuwen, Zhu Xiaojian, Meng Li..
Myeloid-derived suppressor cells—immunotherapy targets in hematological malignancies
[J]. Journal of International Oncology, 2017, 44(4): 313-316.
|
[14] |
Huang Deliang, Yao Zhongping, Zhang Weizhong.
Influence of PD1 inhibitor pembrolizumab on T lymphocyte subsets and NK cells in patients with late stage nonsmall cell lung cancer
[J]. Journal of International Oncology, 2017, 44(3): 169-172.
|
[15] |
Chen Gang, Zhuang Fangcheng.
High mobility group box 1 and its role in cervical cancer
[J]. Journal of International Oncology, 2017, 44(3): 235-238.
|